tiprankstipranks
Advertisement
Advertisement

BIIB Stock Latest News

Biogen price target raised to $241 from $221 at Mizuho
The FlyBiogen price target raised to $241 from $221 at Mizuho
17h ago
BIIB
Biogen price target raised to $215 from $200 at Citi
PremiumThe Fly
Biogen price target raised to $215 from $200 at Citi
2d ago
BIIB
Biogen price target raised to $231 from $222 at Morgan Stanley
PremiumThe Fly
Biogen price target raised to $231 from $222 at Morgan Stanley
6d ago
BIIB
Biogen price target raised to $251 from $237 at H.C. Wainwright
PremiumThe Fly
Biogen price target raised to $251 from $237 at H.C. Wainwright
6d ago
BIIB
Biogen price target lowered to $240 from $242 at RBC Capital
PremiumThe Fly
Biogen price target lowered to $240 from $242 at RBC Capital
6d ago
BIIB
Biogen price target raised to $240 from $225 at UBS
PremiumThe FlyBiogen price target raised to $240 from $225 at UBS
6d ago
BIIB
Biogen price target raised to $215 from $201 at Wedbush
Premium
The Fly
Biogen price target raised to $215 from $201 at Wedbush
6d ago
BIIB
Biogen price target raised to $219 from $215 at BofA
Premium
The Fly
Biogen price target raised to $219 from $215 at BofA
6d ago
BIIB
Biogen price target raised to $225 from $215 at TD Cowen
PremiumThe Fly
Biogen price target raised to $225 from $215 at TD Cowen
6d ago
BIIB
Biogen price target raised to $248 from $245 at Canaccord
PremiumThe Fly
Biogen price target raised to $248 from $245 at Canaccord
6d ago
BIIB
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
PremiumCompany Announcements
Biogen Earnings Call: Growth Engines Offset Near-Term Drag
6d ago
BIIB
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
PremiumRatings
Biogen: Buy Rating Reiterated on Strong Q2 Beat and Upgraded 2026 Outlook; Price Target Maintained at $256
7d ago
BIIB
Morning Movers: Generac, Amphenol climb following earnings
PremiumThe FlyMorning Movers: Generac, Amphenol climb following earnings
7d ago
F
V
Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25
Premium
The Fly
Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25
7d ago
BIIB
Biogen reports Q2 EPS $3.60, consensus $2.05
Premium
The Fly
Biogen reports Q2 EPS $3.60, consensus $2.05
7d ago
BIIB
Biogen price target raised to $200 from $185 at Barclays
PremiumThe Fly
Biogen price target raised to $200 from $185 at Barclays
7d ago
BIIB
Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors
PremiumCompany Announcements
Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors
9d ago
BIIB
BIIB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BIIB Upcoming Earnings Report: What to Expect?
9d ago
BIIB
Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions
PremiumRatings
Biogen: Balanced Risk-Reward Keeps Rating at Hold Amid MS Pressure and Uncertain New Asset Contributions
14d ago
BIIB
Biogen price target raised to $280 from $260 at Guggenheim
PremiumThe FlyBiogen price target raised to $280 from $260 at Guggenheim
15d ago
BIIB
Biogen price target lowered to $215 from $217 at BofA
Premium
The Fly
Biogen price target lowered to $215 from $217 at BofA
15d ago
BIIB
Biogen, Bloom, First Solar, Oklo, NNE Trending With Analysts
Premium
Weekend Updates
Biogen, Bloom, First Solar, Oklo, NNE Trending With Analysts
18d ago
BE
NNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >